CONVERGENCE:

Wearable devices that track bodily functions, rhythms, and movements will be put to the test by Intel and The Michael J. Fox Foundation in order to allow researchers and physicians to measure progression of Parkinson’s disease and to speed progress toward breakthroughs in drug development. Parkinson’s disease is a neurodegenerative brain disease second only to Alzheimer’s in worldwide prevalence. Their collaboration includes a multiphase research study using a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms. Read More